Jove
Visualize
Contact Us

Related Experiment Videos

The Contiform incontinence device - efficacy and patient acceptability.

A R Morris1, K H Moore

  • 1Pelvic Floor Unit, St George Hospital, Pitney Clinical Sciences Building, Level 1, Kogarah, NSW 2117, Sydney, Australia.

International Urogynecology Journal and Pelvic Floor Dysfunction
|December 17, 2003
PubMed
Summary

Contiform effectively reduced urinary incontinence in women, particularly those with moderate to severe symptoms. While mild cases saw no pad test improvement, both groups experienced better quality of life.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bacterial colonization of bladder urothelial cells in women with refractory Detrusor Overactivity: the effects of antibiotic therapy.

Pathogens and disease·2021
Same author

The association between nocturia, hormonal symptoms and bladder parameters in women: an observational study.

BJOG : an international journal of obstetrics and gynaecology·2021
Same author

ASC acts in a caspase-1-independent manner to worsen acute pneumonia caused by Pseudomonas aeruginosa.

Journal of medical microbiology·2018
Same author

Laparoscopic sacrocolpopexy: how low does the mesh go?

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2016
Same author

ATP during early bladder stretch is important for urgency in detrusor overactivity patients.

BioMed research international·2014
Same author

'Urinary incontinence' post-radiotherapy: a diagnostic conundrum.

Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology·2010
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Area of Science:

  • Urology
  • Gynecology
  • Pelvic Floor Disorders

Background:

  • Urodynamic stress incontinence (USI) affects many women.
  • Non-prolapse USI requires effective treatment options.
  • Contiform is a device for USI management.

Purpose of the Study:

  • To evaluate the efficacy of Contiform for treating women with USI.
  • To assess the impact of Contiform on pad test results and quality of life.
  • To determine if treatment outcomes vary by incontinence severity.

Main Methods:

  • A prospective study of 59 women with USI and no prolapse.
  • Treatment involved Contiform insertion.
  • Primary outcome: 24-hour pad test; secondary outcome: Incontinence Impact Questionnaire (IIQ).

Related Experiment Videos

Main Results:

  • 41 women completed the study; median use was 21 days.
  • Overall, a 72% median reduction in urine loss was observed (p<0.0001).
  • Moderate/severe incontinence showed an 85% reduction; mild incontinence showed no significant pad test improvement. Both groups improved on IIQ.

Conclusions:

  • Contiform is an effective treatment for moderate to severe urodynamic stress incontinence.
  • The device is well-tolerated and easy to insert.
  • Further research may be needed for mild USI cases.